![Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants](https://www.mdpi.com/viruses/viruses-14-01332/article_deploy/html/images/viruses-14-01332-g001.png)
Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
![Vaccines | Free Full-Text | Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination Vaccines | Free Full-Text | Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination](https://pub.mdpi-res.com/vaccines/vaccines-10-00874/article_deploy/html/images/vaccines-10-00874-g001-550.jpg?1653894684)
Vaccines | Free Full-Text | Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination
![Vaccines | Free Full-Text | Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia Vaccines | Free Full-Text | Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia](https://pub.mdpi-res.com/vaccines/vaccines-10-02144/article_deploy/html/images/vaccines-10-02144-g001.png?1671015957)
Vaccines | Free Full-Text | Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
![IJMS | Free Full-Text | Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein IJMS | Free Full-Text | Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein](https://www.mdpi.com/ijms/ijms-22-05464/article_deploy/html/images/ijms-22-05464-g001.png)
IJMS | Free Full-Text | Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein
![Children | Free Full-Text | Etiology and Epidemiology of Croup before and throughout the COVID-19 Pandemic, 2018–2022, South Korea Children | Free Full-Text | Etiology and Epidemiology of Croup before and throughout the COVID-19 Pandemic, 2018–2022, South Korea](https://www.mdpi.com/children/children-09-01542/article_deploy/html/images/children-09-01542-g001.png)
Children | Free Full-Text | Etiology and Epidemiology of Croup before and throughout the COVID-19 Pandemic, 2018–2022, South Korea
![Biomedicines | Free Full-Text | Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis Biomedicines | Free Full-Text | Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis](https://pub.mdpi-res.com/biomedicines/biomedicines-09-01303/article_deploy/html/images/biomedicines-09-01303-g001.png?1632394438)
Biomedicines | Free Full-Text | Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
![Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants](https://pub.mdpi-res.com/vaccines/vaccines-09-01409/article_deploy/html/images/vaccines-09-01409-g001.png?1639559783)
Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
![Biomedicines | Free Full-Text | Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines Biomedicines | Free Full-Text | Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines](https://www.mdpi.com/biomedicines/biomedicines-11-00370/article_deploy/html/images/biomedicines-11-00370-g001.png)
Biomedicines | Free Full-Text | Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
![Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants](https://www.mdpi.com/vaccines/vaccines-10-01655/article_deploy/html/images/vaccines-10-01655-g001.png)
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
![Biomolecules | Free Full-Text | COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies Biomolecules | Free Full-Text | COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies](https://www.mdpi.com/biomolecules/biomolecules-11-00993/article_deploy/html/images/biomolecules-11-00993-g001.png)
Biomolecules | Free Full-Text | COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
![Water | Free Full-Text | Genome Sequencing of SARS-CoV-2 Allows Monitoring of Variants of Concern through Wastewater Water | Free Full-Text | Genome Sequencing of SARS-CoV-2 Allows Monitoring of Variants of Concern through Wastewater](https://www.mdpi.com/water/water-13-03018/article_deploy/html/images/water-13-03018-g001.png)
Water | Free Full-Text | Genome Sequencing of SARS-CoV-2 Allows Monitoring of Variants of Concern through Wastewater
![Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers](https://www.mdpi.com/diagnostics/diagnostics-12-00205/article_deploy/html/images/diagnostics-12-00205-g001.png)
Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers
![Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development](https://www.mdpi.com/vaccines/vaccines-09-01052/article_deploy/html/images/vaccines-09-01052-g001.png)
Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
![Vaccines | Free Full-Text | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities Vaccines | Free Full-Text | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities](https://pub.mdpi-res.com/vaccines/vaccines-10-00384/article_deploy/html/images/vaccines-10-00384-g001.png?1646227534)
Vaccines | Free Full-Text | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
![Microorganisms | Free Full-Text | SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo Microorganisms | Free Full-Text | SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo](https://pub.mdpi-res.com/microorganisms/microorganisms-11-01015/article_deploy/html/images/microorganisms-11-01015-g001.png?1681377727)
Microorganisms | Free Full-Text | SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
![Microorganisms | Free Full-Text | COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development Microorganisms | Free Full-Text | COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development](https://pub.mdpi-res.com/microorganisms/microorganisms-10-00598/article_deploy/html/images/microorganisms-10-00598-g001.png?1646908440)
Microorganisms | Free Full-Text | COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
![Viruses | Free Full-Text | A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil Viruses | Free Full-Text | A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil](https://www.mdpi.com/viruses/viruses-13-00724/article_deploy/html/images/viruses-13-00724-g001.png)
Viruses | Free Full-Text | A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil
![Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants | Journal of Virology Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants | Journal of Virology](https://journals.asm.org/cms/asset/8d1e3743-f375-48fb-bb43-ebaebb304214/jvi.2021.95.issue-19.cover.gif)